knowledge -WSS

knowledge

author：hotspot 2025-09-06 06:16:56 - browse：6

A new treatment for Alzheimer’s disease developed by Eli Lilly slowed patients’ rate of cognitive and functional decline by 35% compared to placebo, the company said Wednesday, paving the way for a submission to the Food and Drug Administration and boosting hopes for a new class of Alzheimer’s drugs.

But the positive outcome of the study involving the drug, called donanemab, could be tempered by the deaths of two patients, and possibly a third, from a type of brain swelling caused by these drugs.

The results of the study were reported in a press release and have not yet been reviewed by outside scientists. Lilly said the data will be used to file for full approval with the FDA before the end of June. If cleared, donanemab will compete with another new Alzheimer’s treatment, Leqembi, made by Eisai and Biogen, that secured FDA approval in January.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： There should be a 'Moonshot' or 'Warp Speed' for rare diseases

WSS

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Thousands protest in Iraq for a second day over burning of Quran in Sweden

GOP inquiry over gain

Supreme Court rules employers must be more accommodating of religious observance

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Using force crossed my mind when examining a defiant young patient

Wikipedia

knowledge

focus

The cancer drug shortage isn’t new — and neither are the solutions

Medicare isn't yet testing food as medicine

Walensky prepares to leave CDC — and Congress — behind

The simple reason for the increase in autism diagnosis

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

New air purifier tech could be key to improving indoor air quality

Ukrainian soldiers say they owe lives to US

Heart attack and stroke risk calculators need revising

Medical experts exlpore how to eliminate bias in clinical algorithms

knowledge

Prince Harry seeks over $550,000 in phone hacking lawsuit against British tabloid publisher

Supreme Court strikes down Biden student loan forgiveness program

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Cholera vaccine supplies dangerously low, outbreaks surging

The sun may be out, but guns are not. A lawsuit challenges a new gun ban on Hawaii beaches

Belarusian journalist sentenced to 4 years in prison as crackdown continues

entertainment

explore

leisure time

Wikipedia